Lorazepam Injection
Product Images NDC 0641-6046

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 0641-6046). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lorazepam Injection Structural Formula (Lorazepam Injection Usp Ww 1)

Chemical structure of lorazepam, showing the molecular arrangement including two chlorinated benzene rings, a diazepine ring, and functional groups consistent with the lorazepam molecule.*

FDA Label Image

Lorazepam Injection Usp Ww 10

A product label for Lorazepam injection by Hikma Pharmaceuticals USA Inc. The label includes a GTIN barcode with numeric code, serial number, expiration date placeholder, and lot number placeholder. The dosage strength and route are not visible in this image.*

FDA Label Image

Lorazepam Injection, Usp Civ 2 mg/ml 1 mL Vial (Lorazepam Injection Usp Ww 2)

Lorazepam Injection, USP 2 mg/mL vial label from Hikma Pharmaceuticals USA Inc. The label indicates it is for intramuscular (IM) and intravenous (IV) use, with instructions to dilute for IV use. The vial is 1 mL and requires refrigeration and protection from light. The label also notes it is a prescription drug with space for lot number and expiration date.*

FDA Label Image

Lorazepam Injection, Usp Civ 2 mg/ml 25 X 1 mL Vials (Lorazepam Injection Usp Ww 3)

Lorazepam Injection, USP 2 mg/mL vial label from Hikma Pharmaceuticals USA Inc. The label includes directions indicating the product is for intramuscular and intravenous use, requires dilution for intravenous use, and must be refrigerated. It contains 2 mg lorazepam per mL with specified excipients and advises protecting from light and storing in the carton.*

FDA Label Image

Lorazepam Injection, Usp Civ 20 mg/10 mL (2 mg/ml) 10 mL Multiple Dose Vial (Lorazepam Injection Usp Ww 4)

Lorazepam Injection, USP 4 mg/mL vial label by Hikma Pharmaceuticals USA Inc. for intramuscular and intravenous use. The label instructs to dilute for IV administration, protect from light, refrigerate, and indicates a 1 mL vial.*

FDA Label Image

Lorazepam Injection, Usp Civ 20 mg/10 mL (2 mg/ml) 10 X 10 mL Multiple Dose Vials (Lorazepam Injection Usp Ww 5)

Lorazepam Injection, USP 4 mg/mL vial label. The label indicates it is for intramuscular use and intravenous use with dilution required. It contains 4 mg of lorazepam per mL with preservatives noted. Storage instructions specify refrigeration and protection from light. Manufactured by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Lorazepam Injection, Usp Civ 4 mg/ml 1 mL Vial (Lorazepam Injection Usp Ww 6)

Lorazepam Injection, USP 2 mg/mL (20 mg per 10 mL) vial label for intramuscular and intravenous use. The label indicates a 10 mL multiple dose vial manufactured by Hikma Pharmaceuticals USA Inc. It includes storage instructions to protect from light, refrigerate, and cautions against use if the solution is discolored or precipitated.*

FDA Label Image

Lorazepam Injection, Usp Civ 4 mg/ml 25 X 1 mL Vials (Lorazepam Injection Usp Ww 7)

Lorazepam Injection, USP 2 mg/mL (20 mg per 10 mL) label for intramuscular and intravenous use, requiring dilution. The label specifies refrigeration, multiple 10 mL dose vials, and includes storage instructions, manufacturer Hikma Pharmaceuticals USA Inc., and controlled substance designation IV.*

FDA Label Image

Lorazepam Injection, Usp Civ 40 mg/10 mL (4 mg/ml) 10 mL Multiple Dose Vial (Lorazepam Injection Usp Ww 8)

Label for Lorazepam Injection USP 4 mg/mL, an injectable dosage form for intramuscular or intravenous use requiring dilution. The label indicates a concentration of 40 mg per 10 mL in a multiple-dose vial. It is manufactured by Hikma Pharmaceuticals USA Inc. The label includes storage instructions to protect from light and refrigerate, with warnings against use if the solution is discolored or contains precipitate.*

FDA Label Image

Lorazepam Injection, Usp Civ 40 mg/10 mL (4 mg/ml) 10 X 10 mL Multiple Dose Vials (Lorazepam Injection Usp Ww 9)

Lorazepam Injection USP 4 mg/mL in a 10 mL vial, labeled for intramuscular use and intravenous use with dilution. The label indicates a concentration of 40 mg per 10 mL. It is a refrigerated, multiple dose vial packaged by Hikma Pharmaceuticals USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.